Home

KEVIN KOTLER

CIK 1601692 · last filed 2021-05-13

KEVIN KOTLER is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2015. Across all open-market trades the lifetime net is +$21.4M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

12

Lifetime Open-Market Net

$21.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director 1,729,140 — — -$1.20M 3 2018-12-27
Corium International, Inc. (CORI) Delisted 10%+ Owner 0 — — $0 1 2018-11-28
Societal CDMO, Inc. (REPH) Delisted 10%+ Owner 2,048,025 $2.09 $4.28M $30.92M 3 2018-05-24
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted 10%+ Owner 4,133,464 $21.64 $89.45M -$8.36M 2 2017-06-26

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-05-13 — Buy (P) +900,000 $2.88M
2020-08-11 — Mixed +135,000 $131.8K
2018-12-27 NOVELION THERAPEUTICS INC. (NVLN) Delisted Sell (S) −1,350,003 -$1.20M EDGAR
2018-11-28 Corium International, Inc. (CORI) Delisted U −13,424,985 $0 EDGAR
2018-08-13 NOVELION THERAPEUTICS INC. (NVLN) Delisted Gift (G) — $0 EDGAR
2018-05-24 Societal CDMO, Inc. (REPH) Delisted Sell (S) −564,000 -$3.28M EDGAR
2017-06-26 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −783,000 -$8.36M EDGAR
2017-01-06 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Disp (D) −13,183,392 $0 EDGAR
2016-12-27 NOVELION THERAPEUTICS INC. (NVLN) Delisted Grant (A) — $0 EDGAR
2016-12-14 Societal CDMO, Inc. (REPH) Delisted Buy (P) +1,950,000 $11.70M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.